This article refers to:
Kothari N, Kim R, Jorissen RN, Desai J, Tie J, Wong H-L, Faragher I, Jones I, Day FL, Li S, Sakthinandeswaren A, Palmieri M, Lipton L, Schell M, Teer JK, Shibata D, Yeatman T, Sieber OM, Gibbs P, & Tran B. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. Acta Oncologica, 2016; 54:487–492. DOI: 10.3109/0284186X.2014.990158
When this article was published, the author Ian Faragher’s name was misspelled as Farragher.
The authors apologise for this error.